Conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid (DOTA) and its derivatives to peptides: Synthesis, applications and future prospects

Z. Kovacs, L. M. De León-Rodríguez

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

The universal chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid (DOTA) and its bifunctional derivatives are widely used to label peptides with various metal ions for biomedical applications. Bifunctional DOTA derivatives and their conjugation to peptides has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals. This review covers the synthesis of DOTA-peptide conjugates, their potential use in biomedicine and the problems related to their applications.

Original languageEnglish (US)
Pages (from-to)281-291
Number of pages11
JournalMini-Reviews in Organic Chemistry
Volume4
Issue number4
DOIs
StatePublished - Nov 1 2007

Keywords

  • Conjugation
  • DOTA
  • Diagnostic
  • Labeling
  • Peptides
  • Therapy

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint Dive into the research topics of 'Conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid (DOTA) and its derivatives to peptides: Synthesis, applications and future prospects'. Together they form a unique fingerprint.

  • Cite this